AI.implant Offers No-Cost License to Game Developers

Alex J. Champandard on July 25, 2007

I just received this by email from the team behind the AI.implant middleware solution:

“Engenuity will no longer charge a licensing fee for AI.implant and will now offer perpetual source code agreements in exchange for marketing exposure relating to future titles developed with AI.implant.”

The only catch is you have to be an accredited console developer.

“Qualified Xbox 360 console developers and PLAYSTATION3 game title developers will now have full and complete access to the source code for AI.implant, Engenuity’s highly acclaimed AI middleware solution.

By taking advantage of AI.implant’s perpetual source code agreement you can create more immersive games better and faster, while tailoring the AI.implant core to your specific needs. Save on the expense of game development through the power of AI.implant, a two-time winner of the Game Developer Front Line Award for best middleware.”

According to the email, Midway Games, BioWare, and Vivendi are already using this middleware.

But here’s their motivation:

“With our recent acquisition by CAE, and the growing demand for specific AI functionality in the simulation space, we will be focusing our attention on developing our AI offering for simulation applications,” said Robert Kopersiewich, Vice President of Product Management and Business Development, Engenuity.

“Given our seven years of development in the games community we wanted to ensure that AI.implant’s leadership position in this market would continue. Thus, we are proud to be the first AI middleware solution provider to introduce an adaptable licensing program that addresses the real technical needs of in-house AI middleware integration, as well as removing the financial barriers to owning such cutting-edge technology. We look forward to seeing the gaming community continue to explore new frontiers with AI.implant.”

If that sounds interesting to you, and you fit the criteria, the SDK is available from the AI.implant website.

Discussion 0 Comments

If you'd like to add a comment or question on this page, simply log-in to the site. You can create an account from the sign-up page if necessary... It takes less than a minute!